admin

Acorns president David Hijirida Courtesy: Mo Osborne | Acorns Investing and savings app Acorns has hired a former Amazon executive and fintech CEO to lead day-to-day operations ahead of the start-up’s debut as a public company, CNBC has learned. The company is set to announce Wednesday that it named David Hijirida as president, according to
0 Comments
A pharmaceutical play, Novavax (NASDAQ:NVAX) has been on the move. In fact, NVAX stock has risen nearly three times higher since November of last year. Source: Ascannio/Shutterstock.com This leap is primarily due to the company’s Covid-19 vaccine inching closer to commercial release. However, despite the price appreciation, I believe there is still plenty of upside
0 Comments
Social media traders on communities such as Reddit’s r/WallStreetBets have had an amazing 2021. All of Wall Street stopped what it was doing to watch the excitement in GameStop (NYSE:GME), BlackBerry (NYSE:BB) and other such meme stocks during their historic January short squeezes. After Robinhood (NASDAQ:HOOD) temporarily suspended trading in GME stock and other meme names, however,
0 Comments
In this article GSBD David Zalik, founder and CEO of GreenSky. Chris Hamilton | GreenSky Goldman Sachs is acquiring digital lender GreenSky for $2.24 billion as the investment bank pushes further into consumer finance. The all-stock deal for GreenSky, called the biggest fintech platform for home improvement loans in a release announcing the transaction, is
0 Comments
Something big is going on here. As I’m writing this on Friday, Sept. 10, shares of installment-payment broker Affirm (NASDAQ:AFRM) are up 36% and AFRM stock is the number-one trending ticker on Yahoo Finance. Source: Joaquin Corbalan P / Shutterstock.com This undoubtedly caught many market participants off guard. After all, Affirm isn’t exactly a household name
0 Comments
The Inspiration4 crew in their SpaceX spacesuits, from left: Chris Sembroski, Dr. Sian Proctor, Jared Isaacman, and Hayley Arceneaux John Kraus / Inspiration4 KENNEDY SPACE CENTER, Florida — SpaceX is set to make history as Elon Musk’s space company prepares to launch four civilians to orbit. They will become the first full crew of non-professional astronauts to fly to
0 Comments
Increasing M&A deals and cutting edge therapies are driving biotech ETFs higher. IShares Nasdaq Biotechnology ETF: https://www.zacks.com/funds/etf/IBB/profile?cid=CS-YOUTUBE-FT-VID SPDR S&P Biotech ETF: https://www.zacks.com/funds/etf/XBI/profile?cid=CS-YOUTUBE-FT-VID ARK Genomic Revolution ETF: https://www.zacks.com/funds/etf/ARKG/profile?cid=CS-YOUTUBE-FT-VID Virtus LifeSci Biotech Clinical Trials ETF: https://www.zacks.com/funds/etf/BBC/profile?cid=CS-YOUTUBE-FT-VID ALPS Medical Breakthroughs ETF: https://www.zacks.com/funds/etf/SBIO/profile?cid=CS-YOUTUBE-FT-VID Merck: https://www.zacks.com/stock/quote/MRK?cid=CS-YOUTUBE-FT-VID Biogen: https://www.zacks.com/stock/quote/BIIB?cid=CS-YOUTUBE-FT-VID Sanofi: https://www.zacks.com/stock/quote/SNY?cid=CS-YOUTUBE-FT-VID ArQule: https://www.zacks.com/stock/quote/ARQL?cid=CS-YOUTUBE-FT-VID Synthorx: https://www.zacks.com/stock/quote/THOR?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow
0 Comments